Adding docetaxel to androgen deprivation therapy (ADT) plus radiation therapy (RT) failed to improve survival in unfavorable-risk prostate cancer, though the combination may hold benefit for certain ...

CHRYSALIS-2: A phase 1/1b study of lazertinib as monotherapy and in combination with amivantamab in patients with EGFR-mutant NSCLC. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting ...

There are a number of generic docetaxel products now available in the United States, since the patent on the branded version of docetaxel (Taxotere, Sanofi) expired in 2011. But now, for the first ...

BEDMINSTER, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies ...

The anticancer drug docetaxel (Taxotere ®) is approved for the treatment of patients with locally advanced or metastatic breast or non-small-cell lung cancer and androgen-independent metastatic ...

The novel radiopharmaceutical for prostate cancer, radium Ra223 dichloride (Xofigo), is equally effective whether or not the patient has previously received chemotherapy with docetaxel, a new analysis ...

BEDMINSTER, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies ...

Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer. Thirty-four patients were assessable for disease response; 18 (53%; 95% confidence interval ...

Please provide your email address to receive an email when new articles are posted on . The addition of docetaxel to cisplatin and 5-FU chemotherapy significantly extended OS as neoadjuvant therapy ...

Are you taking Docetaxel? Are you aware of the dangers of combining Docetaxel with certain foods and herbs? Drug-food-interactions are seldom discussed but can lead to undesirable side effects and ...